Related Experiment Video
Updated: Oct 8, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Mosaic PKHD1 in Polycystic Kidneys Caused Aberrant Protein Expression in the Mitochondria and Lysosomes
Chengxian Xu1, Chenxi Yang2, Qing Ye1
1Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, China.
Insights
Autosomal recessive polycystic kidney disease (ARPKD) is a severe genetic kidney disorder. This study reveals PKHD1 gene variants and mosaicism in affected families, highlighting mitochondrial and lysosomal dysfunction in ARPKD pathophysiology.
Area of Science:
- Genetics
- Molecular Biology
- Pathology
Background:
- Autosomal recessive polycystic kidney disease (ARPKD) is a severe genetic renal cystic disease.
- The genetic causes, pathological features, and mechanisms of ARPKD remain incompletely understood.
- The polycystic kidney and hepatic disease 1 (PKHD1) gene is the primary genetic cause of ARPKD.
Purpose of the Study:
- To investigate the genetic basis and pathological mechanisms of ARPKD in a family with affected siblings.
- To characterize the molecular and cellular alterations in ARPKD patients with PKHD1 variants.
- To explore the role of exosome proteomics in understanding ARPKD pathophysiology.
Main Methods:
- Genetic analysis of a family with ARPKD to identify PKHD1 variants.
- Pathological characterization of kidney biopsy samples using microscopy.
- Exosome isolation from patient urine and proteomic analysis.
- Analysis of mitochondrial and lysosomal protein expression and cellular morphology.
Main Results:
- Identified biallelic PKHD1 variants in siblings, including paternal mosaicism for one variant.
- Pathology revealed predominant proximal tubule dilation, defective ciliogenesis, and impaired cell junctions.
- Exosome proteomics showed significant alterations in mitochondrial and lysosomal proteins, with downregulated OXPHOS and upregulated glycolysis.
- Increased abundance of specific lysosomal proteins, including sulfamidase, was observed in patient exosomes.
- Mutant tubular epithelial cells displayed swollen mitochondria and abundant lysosomes.
Conclusions:
- PKHD1 deficiency leads to significant alterations in mitochondrial and lysosomal function, contributing to ARPKD pathophysiology.
- Exosome proteomics offers valuable insights into the molecular mechanisms of ARPKD.
- PKHD1 mosaicism should be considered during genetic testing for ARPKD.
Abstract:
Autosomal recessive polycystic kidney disease (ARPKD) is a severe renal cystic disease caused mainly by the polycystic kidney and hepatic disease 1 (PKHD1). However, the genetic cause, pathologic features, and mechanism of action of ARPKD are not well known. Here, we identified a family with ARPKD. Two siblings harbored biallelic variants in PKHD1 (c.7205G>A, c.7973T>A). We determined that the "de novo" variant, c.7205G>A, arose from the mosaicism of the father and had a 7.4% level. Pathologic characterization, using biopsy analysis, was evidenced with predominant cystic dilation in proximal tubules, slight ectasia of collecting ducts, defective ciliogenesis, and impaired cell-cell junctions in renal tubules and collecting ducts. Exosome proteomics in the urine from patients with ARPKD were markedly different from those of controls, with the most significant alterations occurring in mitochondrial and lysosomal proteins. Expression of the proteins of OXPHOS was downregulated sharply, in parallel with upregulated expression of the proteins involved in glycolysis in patients with ARPKD. Several lysosomal proteins associated with renal lesions were more abundant in the exosome of the patient than in controls. Moreover, the lysosomal enzyme sulfamidase, which is produced by the SGSH gene, was abrupt uniquely in the exosome of the patient. Consistently, swollen mitochondria and abundant lysosomes were visualized in the mutant tubular epithelial cells of patients with mutant PKHD1. Collectively, these findings provide new insights on the pathophysiology of the polycystic kidney due to PKHD1 deficiency. PKHD1 mosaicism should be considered in genetic testing of ARPKD patients.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Related Concept Videos
Lysosomal Hydrolases
Abnormal Proliferation
Nephrons
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Chronic Kidney Disease I: Introduction